Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cantharides + camphor is a topical multi-ingredient pharmaceutical preparation historically used in dermatology, in which **cantharides** provides vesicant activity and **camphor** serves as a counterirritant topical component. Based on the provided context, the therapeutically relevant active blistering component is cantharidin derived from blister beetles, which induces acantholysis in epidermal tissue and has been associated with inhibition of protein phosphatase 1 and protein phosphatase 2A. Preparations containing cantharidin have been used topically for molluscum contagiosum and cutaneous warts; however, the exact named query here refers to the specific combination product term cantharides + camphor rather than a modern standardized single-ingredient cantharidin product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cantharides + camphor.